Cascadian Therapeutics (CASC) Receives Pediatric Investigation Plan Waiver from EMA

January 2, 2018 8:31 AM

Cascadian Therapeutics, Inc. (NASDAQ: CASC), a clinical-stage biopharmaceutical company, today announced that it received a product-specific pediatric waiver from the ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found